Nurse Practitioner, Family · Waterloo, IA
NPI
1861778508
Since 2011
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
2140 Logan Ave Ste B
Waterloo, IA, 50703
Phone (319) 226-8470
Groups this clinician bills Medicare through
Medicare paid, 2024
$51K
3,641 services
Medicare patients, 2024
321
Average age 73
Drug cost, 2024
$548K
3,975 prescriptions
Company payments, 2025
$187
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jessica E Pifkin was code 99214 (office e&m - established), 369 times for 260 patients. In total Jessica E Pifkin billed 3,641 services in 17 codes, and Medicare paid $51K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-02-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 369 | 260 | $71.24 | $26K |
| 99204 Office E&M - New | Office | 56 | 56 | $93.15 | $5,216 |
| 99215 Office E&M - Established | Office | 45 | 41 | $103.62 | $4,663 |
| 36415 Venipuncture Blood Collection | Office | 28 | 28 | $8.65 | $242 |
| 99213 Office E&M - Established | Office | 15 | 15 | $56.79 | $852 |
By year: 2022 $47K for 2,805 services; 2023 $42K for 1,918 services; 2024 $51K for 3,641 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 28 | 28 | $8.65 | $242 |
Medicare prescription drug claims, 2024
In 2024, the drug Jessica E Pifkin prescribed most often to Medicare patients was Gabapentin, with 354 prescriptions and refills. In total Jessica E Pifkin wrote 3,975 Medicare prescriptions that cost $548K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 354 | 574 | 69 | $6,914 |
| Donepezil Hcl Generic | 304 | 511 | 75 | $2,232 |
| Levetiracetam Generic | 293 | 478 | 49 | $6,274 |
| Primidone Generic | 237 | 403 | 47 | $13K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 211 | 304 | 34 | $5,282 |
| Topiramate Generic | 180 | 306 | 32 | $2,244 |
| Memantine Hcl Generic | 151 | 214 | 31 | $2,710 |
| Pregabalin Generic | 150 | 166 | 26 | $1,746 |
| Lamotrigine Generic | 106 | 154 | 17 | $1,349 |
| Duloxetine Hcl Generic | 98 | 153 | 21 | $1,337 |
| Lacosamide Generic | 95 | 95 | 11 | $3,740 |
| Propranolol Hcl Er Propranolol Hcl | 83 | 152 | 20 | $2,942 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 80 | 117 | 15 | $1,752 |
| Nortriptyline Hcl Generic | 76 | 127 | 15 | $1,007 |
| Ropinirole Hcl Generic | 72 | 83 | Under 11 | $1,093 |
Brand drugs: 346 claims; generic drugs: 3,629 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jessica E Pifkin $187 ($187 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $187.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 20 | $187 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.